Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Form 8.3 - Work Group PLC

25 Jul 2017 12:55

RNS Number : 0414M
Maven Capital Partners
25 July 2017
Β 

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Maven Capital Partners UK LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Maven Income and Growth VCT 2 PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC, Maven Income and Growth VCT 6 PLC

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Work Group PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

25 July 2017

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

Β 

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

874,357

3.13

(2) Cash-settled derivatives:

Β 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Β 

TOTAL:

874,357

3.13

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

Β 

Β 

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

Β 

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Β 

Β 

Date of disclosure:

25 July 2017

Contact name:

Graeme Cullen

Telephone number:

0141 206 0110

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RETFELFLDDFEBBZ
Date   Source Headline
18th May 201012:15 pmRNSInterim Management Statement
10th May 201011:38 amRNSTotal Voting Rights
7th May 201011:22 amRNSAnnual Information Update
7th May 201011:04 amRNSTransaction in Own Shares
6th May 20103:41 pmRNSResult of AGM
4th May 20102:46 pmRNSIssue of Equity
6th Apr 201012:32 pmRNSTransaction in Own Shares
6th Apr 201011:25 amRNSIssue of Equity
1st Apr 20105:22 pmRNSIssue of Equity
31st Mar 201011:30 amRNSAnnual Financial Report
10th Mar 20103:34 pmRNSNet Asset Value(s)
26th Jan 201011:15 amRNSLinked Offer for Subscription
26th Jan 201011:15 amRNSLinked Offer for Subscription
26th Jan 201011:15 amRNSLinked Offer for Subscription
26th Jan 201011:15 amRNSLinked Offer for Subscription
5th Jan 201011:21 amRNSTotal Voting Rights
23rd Dec 200911:42 amRNSChange of Name
22nd Dec 20095:23 pmRNSTransaction in Own Shares
18th Dec 200910:04 amRNSStatement re result of General Meeting
16th Dec 200911:48 amRNSTransaction in Own Shares
18th Nov 20091:00 pmRNSNotice of EGM
16th Nov 200912:04 pmRNSInterim Management Statement - Amendment
16th Nov 200911:13 amRNSInterim Management Statement - Amendment
16th Nov 200910:16 amRNSInterim Management Statement
2nd Nov 20094:37 pmRNSChange of Adviser
7th Aug 200912:16 pmRNSHalf Yearly Report
10th Jun 200911:53 amRNSChange of Adviser
1st Jun 200911:30 amRNSAnnual Information Update
15th May 200910:22 amRNSResult of AGM
15th May 200910:12 amRNSInterim Management Statement
7th Apr 200910:52 amRNSDividend Declaration
6th Apr 20094:22 pmRNSAnnual Financial Report
6th Apr 20093:00 pmRNSChange of Adviser
14th Nov 200811:37 amRNSResult of EGM
14th Nov 200811:14 amRNSInterim Management Statement
29th Aug 200812:19 pmRNSCircular re GM, and issue of
14th Aug 200811:31 amRNSInterim Results
7th Aug 200812:49 pmRNSDirectorate Change
19th May 20083:30 pmRNSInterim Management Statement
15th May 20083:50 pmRNSAGM Statement
7th May 20089:30 amRNSAnnual Information Update
6th May 200811:36 amRNSAnnual Report and Accounts
12th Mar 200811:00 amRNSDividend Declaration
28th Feb 20084:36 pmRNSFinal Results
12th Sep 20072:56 pmRNSInterim Results
1st Aug 20071:19 pmRNSTotal Voting Rights
1st Aug 20071:15 pmRNSIssue of Equity
13th Jul 20073:06 pmRNSIssue of Equity
28th Jun 20074:20 pmRNSExtension of Offer period
12th Jun 20074:40 pmRNSAnnual Information Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.